GILD
$108.71
Revenue | $6667Mn |
Net Profits | $1315Mn |
Net Profit Margins | 19.72% |
PE Ratio | 22.69 |
Gilead Sciences Inc.’s revenue fell -0.28% since last year same period to $6667Mn in the Q1 2025. On a quarterly growth basis, Gilead Sciences Inc. has generated -11.92% fall in its revenue since last 3-months.
Gilead Sciences Inc.’s net profit jumped 131.53% since last year same period to $1315Mn in the Q1 2025. On a quarterly growth basis, Gilead Sciences Inc. has generated -26.25% fall in its net profits since last 3-months.
Gilead Sciences Inc.’s net profit margin jumped 131.62% since last year same period to 19.72% in the Q1 2025. On a quarterly growth basis, Gilead Sciences Inc. has generated -16.27% fall in its net profit margins since last 3-months.
Gilead Sciences Inc.’s price-to-earnings ratio after this Q1 2025 earnings stands at 22.69.
EPS Estimate Current Quarter | 1.77 |
EPS Estimate Current Year | 1.77 |
Gilead Sciences Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.77 - a 4.24% jump from last quarter’s estimates.
Gilead Sciences Inc.’s earning per share (EPS) estimates for the current year stand at 1.77.
Earning Per Share (EPS) | 1.81 |
Return on Assets (ROA) | 0.12 |
Return on Equity (ROE) | 0.33 |
Dividend Per Share (DPS) | 0.79 |
Gilead Sciences Inc.’s earning per share (EPS) jumped 237.12% since last year same period to 1.81 in the Q1 2025. This indicates that the Gilead Sciences Inc. has generated 237.12% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Gilead Sciences Inc.’s return on assets (ROA) stands at 0.12.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Gilead Sciences Inc.’s return on equity (ROE) stands at 0.33.
Gilead Sciences Inc. declared 0.79 dividend per share during the earnings announcement for Q1 2025.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-05-07 | 1.77 | 1.81 | 2.11% |